Effect of Fruit Elicitation With Melatonin on Human Health
1 other identifier
interventional
22
1 country
1
Brief Summary
The goal of this clinical trial is to learn if treating fruits with melatonin helps the body absorb and use healthy plant compounds. It will also learn how much melatonin from the fruits is taken up by the body. The main questions it aims to answer are:
- Does melatonin treatment of fruits raise the amount of healthy compounds the body absorbs?
- Does melatonin from treated fruits appear in urine after eating them? Researchers will compare juice made from melatonin-treated fruits to juice made from untreated fruits to see if melatonin changes absorption. Participants will:
- Follow a special low-plant-compound diet for 3 days before each test day
- Drink 300 grams of juice from treated or untreated fruit while fasting
- Provide urine samples before and after drinking the juice
- Return 15 days later to switch to the other juice type
- Repeat this process with lemon, blood orange, and cherry
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Mar 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedFirst Submitted
Initial submission to the registry
September 17, 2025
CompletedFirst Posted
Study publicly available on registry
September 25, 2025
CompletedSeptember 25, 2025
September 1, 2025
5 months
September 17, 2025
September 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Biodisponibility of phenolic compounds and melatonin from melatonin-treated fruits
The primary outcome is the amount of phenolic compounds (flavanones and anthocyanins) and melatonin absorbed and excreted by participants after consuming 300 g of juice from melatonin-treated fruits. Urine samples are collected at 0-3.5 h, 3.5-12 h, and 12-24 h post-consumption, and concentrations are measured using UHPLC-QqQ-MS/MS. Excretion is normalized to creatinine to account for urine volume differences.
0-3.5, 3.5-12, and 12-24 hours post-consumption for each intervention period
Study Arms (2)
Melatonin-treated fruit first, then control fruit
EXPERIMENTALParticipants will consume juice prepared from melatonin-treated fruits (lemon, blood orange, or sweet cherry) during the first intervention period, followed by juice from untreated control fruits after a 15-day washout period. Urine samples will be collected at specified intervals to measure bioactive compound absorption and metabolism.
Control fruit first, then melatonin-treated fruit
EXPERIMENTALParticipants will consume juice prepared from untreated control fruits (lemon, blood orange, or sweet cherry) during the first intervention period, followed by juice from melatonin-treated fruits after a 15-day washout period. Urine samples will be collected at specified intervals to measure bioactive compound absorption and metabolism.
Interventions
Participants will consume 300 g of juice prepared from untreated fruits (lemon, blood orange, or sweet cherry) under fasting conditions on the intervention day. Urine samples will be collected at 0-3.5 h, 3.5-12 h, and 12-24 h post-consumption to assess absorption and metabolism of bioactive compounds.
Participants will consume 300 g of juice prepared from fruits (lemon, blood orange, or sweet cherry) treated preharvest with melatonin (0.1, 0.3, or 0.5 mM). Juice will be consumed under fasting conditions on the intervention day. Urine samples will be collected at 0-3.5 h, 3.5-12 h, and 12-24 h post-consumption to assess absorption and metabolism of bioactive compounds.
Eligibility Criteria
You may qualify if:
- Healthy adults aged 18-65 years
- Body mass index (BMI) between 18.5 and 24.9 kg/m²
- Non-smokers
- No chronic diseases (such as diabetes, cardiovascular disease, or cancer)
- Not taking regular medication
- Willing to follow a diet low in phenolic compounds and melatonin during the study periods
- Able and willing to provide urine samples according to study instructions
You may not qualify if:
- Presence of chronic diseases or metabolic disorders
- Use of medications that could affect metabolism or absorption of compounds
- Smoking or use of nicotine products
- Allergies or intolerance to citrus fruits or cherries
- Pregnancy or breastfeeding
- Inability or unwillingness to comply with study procedures or dietary restrictions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Miguel Hernandez
Orihuela, Alicante/Alacant, 03312, Spain
Related Publications (2)
Agullo V, Villano D, Garcia-Viguera C, Dominguez-Perles R. Anthocyanin Metabolites in Human Urine after the Intake of New Functional Beverages. Molecules. 2020 Jan 16;25(2):371. doi: 10.3390/molecules25020371.
PMID: 31963236BACKGROUNDAgullo V, Dominguez-Perles R, Moreno DA, Zafrilla P, Garcia-Viguera C. Alternative Sweeteners Modify the Urinary Excretion of Flavanones Metabolites Ingested through a New Maqui-Berry Beverage. Foods. 2020 Jan 3;9(1):41. doi: 10.3390/foods9010041.
PMID: 31947712BACKGROUND
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
September 17, 2025
First Posted
September 25, 2025
Study Start
March 1, 2025
Primary Completion
August 1, 2025
Study Completion
August 1, 2025
Last Updated
September 25, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share